Association Between PD-L1 Expression and Efficacy of Chemoimmunotherapy in Extensive-stage Small Cell Lung Cancer
Patients who tested positive for IC had a significantly longer PFS than those who tested negative. Thus, PD-L1 expression may be a predictive factor of efficacy of chemoimmunotherapy in extensive-stage small cell lung cancer.
Authors
- Ninso Matsunaga
- Yasuhito Fujisaka (ORCID: https://orcid.org/0000-0002-9175-3627)
- Yosuke Shimazu (ORCID: https://orcid.org/0000-0002-7696-7811)
- Hiroyuki Tsuji (ORCID: https://orcid.org/0000-0002-6444-559X)
- Akihisa Imagawa
- SHO MITSUYA
- Shigeru Kawabata (ORCID: https://orcid.org/0000-0003-3948-4500)
- Tomoya Funamoto
- Yosuke Tamura (ORCID: https://orcid.org/0000-0002-8771-1483)
- Takahiko Nakamura (ORCID: https://orcid.org/0000-0003-3604-6927)
- Masahiro Arai (ORCID: https://orcid.org/0000-0002-6312-6319)
- Soichiro Ikeda
- Kenjiro Tsuruoka
Institutions
- Osaka University of Pharmaceutical Sciences (JP)
Publication Details
- Journal
- Anticancer Research
- Published
- 2024-12-01
- DOI
- https://doi.org/10.21873/anticanres.17379
- Citations
- 1
- Primary Topic
- Lung Cancer Research Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.28